“…Herzon, [1][2][3] Reisman, [4] Trauner, [5,6] Castle, [7,8] and very recently Zhu [9] and Nagasawa. [10,11] Origins of such intensive research interest are apparently caused not by bioactivity of hasubanan alkaloids itself, which is scarcely reported, [12] but of their derivatives and more complex structural analogs. In this respect, the report on antiamnesic properties and selective T-cell cytotoxicity of the related alkaloid acutumine, [13] as well as disputed affinity of ent-hasubanans to opioid receptors, [14,15] may have become the triggering factors.…”